|Bid||2.6500 x 3000|
|Ask||2.8500 x 900|
|Day's Range||2.6973 - 2.8850|
|52 Week Range||2.6973 - 9.1700|
|Beta (3Y Monthly)||0.13|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say about hedge funds’ stock picking abilities to illustrate. The Standard and Poor’s 500 Index returned approximately 20% in 2019 (through September 30th). Conversely, hedge […]
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Does Marker Therapeutics, Inc. (NASDAQ:MRKR) represent a good buying opportunity at the moment? Let’s quickly check the hedge fund interest towards the company. Hedge fund firms constantly search out bright intellectuals and highly-experienced employees and throw away millions of dollars on satellite photos and other research activities, so it is no wonder why they tend […]
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...
MARKER THERAPEUTICS, INC. (MRKR) delivered earnings and revenue surprises of 7.69% and -100.00%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured expert Kevin Matras highlights: Methode Electronics, Walker & Dunlop, Marker Therapeutics, Chemed and Olympic Steel
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Anyone researching Marker Therapeutics, Inc. (NASDAQ:MRKR) might Read More...